https://sanmarinotechnews.com/article/906832668-kimmtrak-doubles-the-likelihood-of-being-alive-at-five-years-for-first-line-hla-a-02-01-patients-with-metastatic-uveal-melanoma San Marino Tech News en PressRelease 2026-04-19T22:00:00+00:00 KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma https://ml-eu.globenewswire.com/media/bcaafaab-2536-4b4b-899c-9913925b6e4b/small/immunocore-logo-2018.png https://sanmarinotechnews.com/article/906832675-xenon-presents-azetukalner-phase-3-x-tole2-study-results-and-48-month-long-term-data-in-focal-onset-seizures-at-2026-aan-annual-meeting San Marino Tech News en PressRelease 2026-04-19T22:00:00+00:00 Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting https://ml.globenewswire.com/media/505b89d3-dfd1-46e8-bc3b-3c9c699ef7ec/small/xenon-logo-tm-full-color-250x80px-png.png https://sanmarinotechnews.com/article/906816139-transactions-in-zealand-pharma-shares-and-or-related-securities-by-persons-discharging-managerial-responsibilities-and-or-their-closely-associated San Marino Tech News en PressRelease 2026-04-19T20:05:00+00:00 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons https://ml-eu.globenewswire.com/media/31b5d115-c4a3-4dfd-b20e-d222199c4862/small/zealand-logo-1-png.png https://sanmarinotechnews.com/article/906816100-zealand-pharma-launches-long-term-incentive-programs-for-zealand-pharma-s-board-of-directors-corporate-management-and-employees-for-2026 San Marino Tech News en PressRelease 2026-04-19T20:00:00+00:00 Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2026 https://ml-eu.globenewswire.com/media/31b5d115-c4a3-4dfd-b20e-d222199c4862/small/zealand-logo-1-png.png https://sanmarinotechnews.com/article/906800541-revolution-medicines-to-present-updated-phase-1-clinical-data-for-zoldonrasib-in-patients-with-previously-treated-kras-g12d-non-small-cell-lung-cancer San Marino Tech News en PressRelease 2026-04-19T18:00:00+00:00 Revolution Medicines to Present Updated Phase 1 Clinical Data for Zoldonrasib in Patients with Previously Treated KRAS G12D Non-Small Cell Lung Cancer at the 2026 AACR Annual Meeting https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png https://sanmarinotechnews.com/article/906732361-cregis-shines-at-paris-blockchain-week-2026-accelerating-european-expansion San Marino Tech News en PressRelease 2026-04-19T09:45:18+00:00 Cregis Shines at Paris Blockchain Week 2026, Accelerating European Expansion https://ml.globenewswire.com/media/5bebd304-3269-4385-9874-50701ff2353a/medium/cover-image.jpeg https://sanmarinotechnews.com/article/906711088-challenge-accepted-schneider-electric-helps-industry-turn-toughest-problems-into-competitive-advantage San Marino Tech News en PressRelease 2026-04-19T07:00:00+00:00 Challenge accepted: Schneider Electric helps industry turn toughest problems into competitive advantage https://ml.globenewswire.com/media/f9f1757e-4ed3-4fe7-939b-35cd2b1f43e1/medium/schneider-electric.jpg https://sanmarinotechnews.com/article/906674833-direct-meds-glp-1-2026-claims-examined-pricing-verified-what-consumers-should-confirm-before-buying San Marino Tech News en PressRelease 2026-04-19T03:39:34+00:00 Direct Meds GLP-1 2026: Claims Examined, Pricing Verified & What Consumers Should Confirm Before Buying https://ml.globenewswire.com/media/065e49c6-04a6-4223-a1ee-caea644c6a7f/medium/direct-meds.PNG https://sanmarinotechnews.com/article/906674828-strovemont-capital-claims-evaluated-is-strovemont-capital-trading-platform-legit-hidden-features-trust-facts-real-user-results San Marino Tech News en PressRelease 2026-04-19T03:10:24+00:00 Strovemont Capital Claims Evaluated: Is Strovemont Capital Trading Platform Legit? Hidden Features, Trust Facts & Real User Results https://ml.globenewswire.com/media/6c80b7b0-a3e5-46d9-a0a2-28f7c0c723bc/medium/strovemont-capital.png https://sanmarinotechnews.com/article/906659883-bramridge-trust-unveiled-should-you-join-bramridge-trust-features-performance-fees-real-user-insights San Marino Tech News en PressRelease 2026-04-19T02:30:20+00:00 Bramridge Trust Unveiled: Should You Join Bramridge Trust? Features, Performance, Fees & Real User Insights! https://ml.globenewswire.com/media/298d2649-26e8-49ac-ab07-531c079947cf/medium/bramridge-trust.PNG https://sanmarinotechnews.com/article/906622428-crypto-news-alphapepe-ai-dex-demo-over-1000-users-whilst-xrp-price-prediction-targets-5-00-following-official-sec-commodity-status San Marino Tech News en PressRelease 2026-04-18T22:45:00+00:00 Crypto News: AlphaPepe AI DEX Demo Over 1000 Users Whilst XRP Price Prediction Targets $5.00 Following Official SEC Commodity Status https://ml.globenewswire.com/media/bb8173de-d338-4af5-9802-2bcdb498429b/medium/alphapepe.jpg https://sanmarinotechnews.com/article/906577634-pliant-therapeutics-announces-presentation-of-updated-data-from-the-phase-1-trial-of-pln-101095-in-patients-with-ici-refractory-solid-tumors-at-the San Marino Tech News en PressRelease 2026-04-18T17:31:00+00:00 Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting https://ml.globenewswire.com/media/e31d4c37-738e-4662-861d-675c8c564317/medium/figure-1.jpg https://sanmarinotechnews.com/article/906577667-ring-a-ding-launches-openclaw-skill-for-ai-agent-phone-calls San Marino Tech News en PressRelease 2026-04-18T17:18:25+00:00 Ring-a-Ding Launches OpenClaw Skill for AI Agent Phone Calls https://ml.globenewswire.com/Resource/Download/d39b62af-4928-42e0-a75f-20e6a819ac8a/screenshot-2026-04-15-at-14-00-39.png https://sanmarinotechnews.com/article/906577555-theriva-biologics-anuncia-la-pr-xima-presentaci-n-de-datos-adicionales-del-ensayo-cl-nico-virage-de-fase-2b-del-vcn-01-para-el-c-ncer-de-p-ncreas San Marino Tech News en PressRelease 2026-04-18T17:17:08+00:00 Theriva™ Biologics anuncia la próxima presentación de datos adicionales del ensayo clínico VIRAGE de Fase 2b del VCN-01 para el cáncer de páncreas metastásico en la Reunión Anual de la AACR de 2026 https://ml.globenewswire.com/media/ed41908b-8799-4f56-bc3c-acff4f4872eb/small/tovx-logo-jpg.jpg https://sanmarinotechnews.com/article/906525665-other-world-computing-owc-launches-macdrive-12-at-nab-2026-one-solution-for-complete-mac-disk-access-on-windows-including-native-encrypted-apfs San Marino Tech News en PressRelease 2026-04-18T12:30:00+00:00 Other World Computing (OWC) Launches MacDrive 12 at NAB 2026 – One Solution for Complete Mac Disk Access on Windows - Including Native Encrypted APFS Support https://ml.globenewswire.com/media/543d94b6-063b-4931-b524-f7b75a9d230c/medium/owc-macdrive-12-application-window-screenshot.png https://sanmarinotechnews.com/article/906525713-other-world-computing-launches-owc-express-4m2-ultra-at-nab-2026-thunderbolt-5-four-slot-nvme-m-2-ssd-enclosure San Marino Tech News en PressRelease 2026-04-18T12:30:00+00:00 Other World Computing Launches OWC Express 4M2 Ultra at NAB 2026 – Thunderbolt 5 Four-Slot NVMe M.2 SSD Enclosure https://ml.globenewswire.com/media/d50919d2-169d-4edd-8afc-6ca3693ad99d/medium/owc-4m2-ultra-front.png https://sanmarinotechnews.com/article/906526269-tradull-develops-structured-framework-to-improve-visibility-in-commodity-trade-processes San Marino Tech News en PressRelease 2026-04-18T11:36:23+00:00 Tradull Develops Structured Framework to Improve Visibility in Commodity Trade Processes https://ml.globenewswire.com/media/e0fbd3ef-5565-4bc7-a9c9-d9d1acca96a6/medium/tradull.jpg https://sanmarinotechnews.com/article/906501406-press-release-escmid-sanofi-s-nuvaxovid-covid-19-vaccine-showed-better-tolerability-than-mnexspike-in-head-to-head-study San Marino Tech News en PressRelease 2026-04-18T10:00:00+00:00 Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://sanmarinotechnews.com/article/906501531-communiqu-de-presse-escmid-le-nuvaxovid-vaccin-contre-la-covid-19-de-sanofi-a-montr-une-meilleure-tol-rance-que-le-mnexspike-dans-une-tude San Marino Tech News en PressRelease 2026-04-18T10:00:00+00:00 Communiqué de presse : ESCMID : Le Nuvaxovid, vaccin contre la COVID-19 de Sanofi, a montré une meilleure tolérance que le mNEXSPIKE dans une étude comparative directe   https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://sanmarinotechnews.com/article/906476329-crypto-news-alphapepe-announces-880k-raised-while-ethereum-price-prediction-targets-4-000-on-heavy-whale-accumulation San Marino Tech News en PressRelease 2026-04-18T07:00:00+00:00 Crypto News: AlphaPepe Announces $880k Raised While Ethereum Price Prediction Targets $4,000 on Heavy Whale Accumulation https://ml.globenewswire.com/media/64727b55-920f-41c6-8367-978501174859/medium/alphapepe.jpg https://sanmarinotechnews.com/article/906451168-argenx-brings-neuromuscular-leadership-to-aan-2026-with-new-data-supporting-broader-vyvgart-use-across-mg-and-cidp San Marino Tech News en PressRelease 2026-04-18T05:00:00+00:00 argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png https://sanmarinotechnews.com/article/906400487-redcloud-holdings-plc-receives-notice-regarding-minimum-bid-price-requirement San Marino Tech News en PressRelease 2026-04-18T00:15:00+00:00 RedCloud Holdings Plc Receives Notice Regarding Minimum Bid Price Requirement https://ml.globenewswire.com/media/5c1cfb28-9945-43bb-a5bc-7789676cae2f/small/2023-redcloud-product-logos-13-e1691517467929-png.png